Results 121 to 130 of about 17,859 (212)

Modification of the myometrial relaxing effect of nifedipine in vitro and in vivo [PDF]

, 2011
Hajagos-Tóth, Judit
core  

Single vs Dual Lactose-Polyethylene Glycol 3000 Microcarrier Systems for Pulmonary Salmeterol and Fluticasone Targeted Delivery. [PDF]

Drug Des Devel Ther
Akram MW, Zainudin BH, Mohamed Tenang ME, Wong TW.   +3 more
europepmc   +1 more source

Relative Bioavailability of Inhaled Fluticasone Propionate and Salmeterol - is Population Pharmacokinetic Modelling a Relevant Alternative to a Non-Compartmental Approach? [PDF]

Drug Des Devel Ther
Rosenborg J, Bäckman P, Bengtsson T, Haughie S.   +3 more
europepmc   +1 more source

Tracheobronchopathia osteochondroplastica: A rare case report. [PDF]

Medicine (Baltimore)
Xu C, Wang X, Yin X, Wang X, Liu X, Zhou L, Du F, Jiang Y, Su D, Wang Y.   +9 more
europepmc   +1 more source

The comparative effectiveness and safety of fluticasone-salmeterol via metered-dose versus dry powder inhalers for COPD: A new user cohort study. [PDF]

PLoS Med
Demkowicz BJ, Rader K, Wang SV, Kesselheim AS, Feldman WB.   +4 more
europepmc   +1 more source

A Longitudinal Assessment of Greenhouse Gas Emissions From Inhaler Devices in a National Health System. [PDF]

JAMA
Weppner WG, Singh H, Boyd J, Smith G, Chesebro BB.   +4 more
europepmc   +1 more source

Biased Signaling and Its Role in the Genesis of Short- and Long-Acting β₂-Adrenoceptor Agonists. [PDF]

Biochemistry
Phan NTN, Borrega-Roman L, Hoare BL, Harwood CR, Geary N, Guba W, Han Y, Zenko V, Koers EJ, Rufer AC, Grether U, Veprintsev DB, Sykes DA.   +12 more
europepmc   +1 more source

Fluticasone- vs Budesonide-Based Dual Therapy for COPD.

JAMA Netw Open
Feldman WB, Ambati VL, Suissa S, Kesselheim AS, Avorn J, Schneeweiss S, Wang SV.   +6 more
europepmc   +1 more source

Montelukast: risk of mental disorders vs. efficacy-a meta-analysis. [PDF]

Front Pharmacol
Sobczak M, Pawliczak R.
europepmc   +1 more source

Explore impact of inhaled glucocorticoids/β₂-agonists on the oropharyngeal microbiota in asthma patients impact of GCs/β₂-agonists on oropharyngeal microbiota in asthma. [PDF]

Medicine (Baltimore)
Yang Y, Liu Y, Wang R, Liu J, Cui M, Duan Z.   +5 more
europepmc   +1 more source